ArticleFrontiers in immunology2022

Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma.

Yichen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.